Subsidiary of Zhejiang Orient Gene Biotech (688298.SH) obtains medical device registration certificate.
Dongfang Biology (688298.SH) has issued an announcement, stating that its subsidiary Shanghai Huizijian Biological Technology Co., Ltd. and He...
Zhejiang Orient Gene Biotech (688298.SH) has announced that its subsidiary, Shanghai Wanzijian Biotechnology Co., Ltd. and Healgen Scientific LLC (referred to as "American Healgen"), have obtained medical device registration certificates for multiple products in China, Australia, and Singapore recently.
The above-mentioned registered products have enriched the company's flow cytometry technology platform product range. The respiratory tract three-in-one test product has expanded the international market for sale, which is beneficial for the overall expansion of related products in domestic and foreign markets.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
